bioXXmed AG (FRA:T5O)

Market Cap	222.93K -62.6%
Revenue (ttm)	20.49K +310.4%
Net Income	-890.91K
EPS	-3.28
Shares Out	271.87K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.8200
Previous Close	0.8000
Day's Range	0.8200 - 0.8200
52-Week Range	0.0050 - 2.7500
Beta	5.00
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 19, 2026

About bioXXmed AG

bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. bioXXmed AG was founded in 2000 and is based in Heidelberg, Germany.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2000
• Employees: 1
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: T5O

Financial Performance

In 2024, bioXXmed AG's revenue was 3,493, a decrease of -79.93% compared to the previous year's 17,404. Losses were -996,907, -95.24% less than in 2023.